Effectiveness and Safety of Additive Therapy and Monotherapy of Glaucoma with Prostamides
Increased intraocular pressure (IOP) is the main risk factor for the development of primary open-angle glaucoma (POAG). Nowadays medicine that reduce IOP remain the main method of treating for POAG. The first-line drugs for POAG are prostaglandin analogues. In Russia, for the first time, it appeared...
Main Authors: | I. R. Gazizova, S. R. Zainullina, E. B. Martynova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2019-10-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/1016 |
Similar Items
-
The efficiency of monotherapy of patients with primary open-angle glaucoma with Bimatoprost 0.03 % (Bimoptic)
by: S. A. Korotkikh, et al.
Published: (2018-12-01) -
Initial hypotensive therapy of primary glaucoma with the domestic latanoprost generic: efficacy and safety
by: S. Yu. Petrov, et al.
Published: (2022-01-01) -
Incidence of Primary Glaucoma in a Cohort of Nuclear Workers
by: E. V. Bragin, et al.
Published: (2021-10-01) -
The psychology of a glaucoma patient
by: L. M. Gabdrakhmanov, et al.
Published: (2020-09-01) -
Preservative free travoprost and timolol fixed combination in the initial treatment of primary glaucoma: an assessment of hypotensive efficiency and safety
by: S. Yu. Petrov, et al.
Published: (2022-01-01)